Emily is the US General Manager for Novartis Gene Therapies. She joined Novartis in 2004 and, during her tenure, has been in a variety of commercial roles including Business Analytics, Marketing, Market Access and Sales.

Prior to joining Novartis, Emily was a management consultant and practiced as a pharmacist. She holds an MBA from Ivey Business School at the University of Western Ontario and a Bachelor of Science in Pharmacy from the University of British Columbia.

Emily has great passion for maintaining a nimble organization that supports patients in gaining swift access to our transformative therapies.